Reducing the number of surveillance colonoscopies with faecal immunochemical tests

We read with interest the article by Cross et al ,1 which examined the use of FIT in intermediate risk patients undergoing 3 yearly surveillance colonoscopies. The investigators assessed the diagnostic accuracy of this approach, together with the number of advanced adenomas and colorectal cancers missed, and the potential cost savings. The results indicate that replacing 3 yearly colonoscopy with annual FIT (with a positivity threshold of 40 µg...